Covid-19 Tests

Semi-quantitative ELISA test of 48 or 96 wells quantifying IgG antibodies against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens.

Semi-quantitative ELISA test of 48 or 96 wells quantifying IgM antibodies against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens.

Semi-quantitative ELISA test of 48 or 96 wells quantifying IgA, IgM, IgG antibodies against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens.

The Bio-Shield Surface Ag 2019-nCov is an ELISA test for the measurement of SARS-CoV-2 Nucleocapsid Protein (NP) in swabs of common surfaces.
The test is intended for environmental swabbing of larger facilities & spaces and is adequate for up to 48 sample definitions at a time.

Purification of DNA and/or RNA: for DNA and RNA from cell-free media (serum, plasma, body fluids and the supernatant from viral infected cell cultures)

Rapid Test Ag 2019-nCov is a lateral flow test with high sensitivity for the detection of SARS-CoV-2 antigen (nucleocapsid protein) in nasal or nasopharyngeal swab specimens.
It helps to rapidly identify infected individuals, enabling prompt clinical decisions and preventing a potential virus outbreak. The test does not require any special instrument and can be used in all types of premises.

The Rapid Surface Ag 2019-nCov is a rapid test for the detection of SARS-CoV-2 Nucleocapsid Protein Antigen (NP) in swabs of common surfaces, such as metal, plastic, glass, paper, and stainless steel. It is the first product for COVID-19 surface testing to utilize this innovative methodology.
The Rapid Surface Ag 2019-nCov is a valuable tool for several sectors enabling the companies to monitor and mitigate the spread of COVID-19 in their facilities and maintain a safe operating environment.

Ready-to-use solution, supplied in an easy-to-use Spray Bottle, for eliminating RNase, DNase, and other enzymes, as well as DNA contamination, from laboratory surfaces and material. Simply spray on the contaminated area and wipe away from the surface using ultrapure water.

Detection of RNA of SARS-CoV strains including SARS-CoV-2 and SARS-like CoV without discriminating between strains.
Detection of the virus is responsible for the disease COVID-19 (corona virus disease 2019) and also detection of the new SARS-CoV-2 variant from the UK B1.1.7 (VOC-202012/01), the Delta variant and the variant from South Africa B.1.1.529.

Detection of the nucleocapsid protein gene (N gene) of SARS-CoV-2, SARS-CoV and SARS-related coronavirus (Sarbecovirus) and as well as the RdRp gene of SARS-CoV-2

Detection of RNA of the nucleocapsid protein gene of coronavirus SARS-CoV-2, SARS-CoV and SARS-like CoV and influenza A/B virus